LLY
Eli Lilly and Company
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $86.5B | +21.6% |
| Gross profit | $72.3B | +23.2% |
| Net income | $27.6B | +27.2% |
| EPS | $30.81 | +27.6% |
| Free cash flow | $19.7B | +11.9% |
Eli Lilly and Company
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $86.5B | +21.6% |
| Gross profit | $72.3B | +23.2% |
| Net income | $27.6B | +27.2% |
| EPS | $30.81 | +27.6% |
| Free cash flow | $19.7B | +11.9% |